Is angiotensin I-converting enzyme a "master" disease gene?

Diabetes Technology and Therapeutics

Volumn 4, Issue 5, 2002, Pages 683-711

  Moskowitz, David W ^a  

^a GenoMed Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; PROTEIN;

ADULT DISEASE; CANCER; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; GENE; GENE DELETION; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MENTAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRANCE; GENE FREQUENCY; GENETIC DISEASES, INBORN; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX CHARACTERISTICS; UNITED STATES;

EID: 0036412170     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/152091502320798321     Document Type: Review

References (82)

1. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
2. Yoneya K, Okamoto H, Machida M, Onozuka H, Noguchi M, Mikami T, Kawaguchi H, Murakami M, Uede T, Kitabatake A: Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy. Am Heart J 1995;130:1089-1093.
3. Lechin M, Quinones MA, Omran A, Hill R, Yu QT, Rakowski H, Wigle D, Liew CC, Sole M, Roberts R, Marian A: Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995;92:1808-1812.
4. Prasad N, O'Kane KP, Johnstone HA, Wheeldon NM, McMahon AD, Webb DJ, MacDonald TM: The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele. Q J Med 1994;87:659-662.
5. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M: DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994;90:2622-2628.
6. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GA: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-1638.
7. Marian AJ, Yu QT, Workman R, Greve G, Roberts R: Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993;342:1085-1086.
8. Lindpaintner K, Lee M, Larson MG, Rao VS, Pfeffer MA, Ordovas JM, Schaefer EJ, Wilson AF, Wilson PW, Vasan RS, Myers RH, Levy D: Absence of an association or genetic linkage between the angiotensin-converting enzyme gene and left ventricular mass. N Engl J Med 1996;334:1023-1028.
9. Wong KK, Summers KM, Burstow DJ, West MJ: Angiotensin-converting enzyme and angiotensinogen genes in patterns of left ventricular hypertrophy and in diastolic dysfunction. Clin Exp Pharmacol Physiol 1995;22:438-440.
10. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ: Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 1994;267: H1107-H1111.
11. Harn HJ, Chang CY, Ho LI, Liu CA, Jeng JR, Lin FG, Jent-Wei: Evidence that polymorphism of the angiotensin I converting enzyme gene may be related to idiopathic dilated cardiomyopathy in the Chinese population. Biochem Mol Biol Int 1995;35:1175-1181.
12. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perryman MB: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993;342:1073-1075.
13. Duru K, Farrow S, Wang JM, Lockette W, Kurtz T: Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens 1994;7:759-762.
14. Bloem LJ, Manatunga AK, Pratt JH: Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension 1996;27:62-66.
15. Arbustini E, Grasso M, Fasani R, Klersy C, Diegoli M, Porcu E, Banchieri N, Fortina P, Danesino C, Specchia G: Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br Heart J 1995;74:584-591.
16. Castellano M, Muiesan ML, Rizzoni D, Beschi M, Pasini G, Cinelli A, Salvetti M, Porteri E, Bettoni G, Kreutz R, Lindpaintner K, Rosei EA: Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study. Circulation 1995;91:2721-2724.
17. Ishigami T, Iwamoto T, Tamura K, Yamaguchi S, Iwasawa K, Uchino K, Umemura S, Ishii M: Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan. Ethnic difference of ACE genotype. Am J Hypertens 1995;8:95-97.
18. Gu XX, Spaepen M, Guo C, Fagard R, Amery A, Lijnen P, Cassiman JJ: Lack of association between the I/D polymorphism of the angiotensin-converting enzyme gene and essential hypertension in a Belgian population. J Hum Hypertens 1994;8:683-685.
19. Morris BJ, Zee RY, Schrader AP: Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest 1994;94:1085-1089.
20. Berge KE, Berg K: No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability. Clin Genet 1994;45:169-174.
21. Summers KM, West JA, Huggard PR, West MJ: Angiotensin-converting enzyme and regulation of blood pressure in a large Australian family. Clin Exp Pharmacol Physiol 1993;20:320-323.
22. Schmidt S, Van Hooft IM, Grobbee DE, Ganten D, Ritz E: Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens 1993;11:345-348.
23. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, Miki T, Mikami H, Ogihara T: Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun 1993;191:399-404.
24. Zee RY, Lou YK, Griffiths LR, Morris BJ: Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992;184:9-15.
25. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel J-M: Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992;1:72-75.
26. Ohishi M, Fujii K, Minamino T, Higaki J, Kamitani A, Rakugi H, Zhao Y, Mikami H, Miki T, Ogihara T: A potent genetic risk factor for restenosis. Nat Genet 1993;5:324-325.
27. van Bockxmeer FM, Mamotte CD, Gibbons FA, Burke V, Taylor RR: Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation 1995;92:2066-2071.
28. Hamon M, Bauters C, Amant C, McFadden EP, Helbecque N, Lablanche JM, Bertrand ME, Amouyel P: Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. Circulation 1995;92:296-299.
29. Samani NJ, Martin DS, Brack M, Cullen J, Wallis R, Lodwick D, Chauhan A, Harley A, Thompson JR, Gershlick AH, de Bono DP: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancet 1995;345:1013-1016.
30. Gardemann A, Weiss T, Schwartz O, Eberbach A, Katz N, Hehrlein FW, Tillmanns H, Waas W, Haberbosch W: Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation 1995;92:2796-2799.
31. Schuster H, Wienker TF, Stremmler U, Noll B, Steinmetz A, Luft FC: An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction in women but not in men. Am J Cardiol 1995;76:601-603.
32. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH: Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995;91:2120-2124.
33. Leatham E, Barley J, Redwood S, Hussein W, Carter N, Jeffery S, Bath PM, Camm A: Angiotensin-1 converting enzyme (ACE) polymorphism in patients presenting with myocardial infarction or unstable angina. J Hum Hypertens 1994;8:635-638.
34. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644.
35. Lindpaintner K, Pfeifer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711.
36. Takahashi K, Nakamura H, Kubota I, Takahashi N, Tomoike H: Association of ACE gene polymorphisms with coronary artery disease in a northern area of Japan. Jpn Heart J 1995;36:557-564.
37. Wang XL, McCredie RM, Wilcken DE: Genotype distribution of angiotensin-converting enzyme polymorphism in Australian healthy and coronary populations and relevance to myocardial infarction and coronary artery disease. Arterioscler Thromb Vasc Biol 1996;16:115-119.
38. Perola M, Sajantila A, Sarti C, Stengard J, Tamminen M, Puska P, Huttunen J, Tuomilehto J, Peltonen L: Angiotensin-converting enzyme genotypes in the high- and low-risk area for coronary heart disease in Finland. Genet Epidemiol 1995;12:391-399.
39. Beohar N, Damaraju S, Prather A, Yu QT, Raizner A, Kleiman NS, Roberts R, Marian AJ: Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. J Invest Med 1995;43:275-280.
40. Nakai K, Itoh C, Miura Y, Nakai K, Syo T, Musya T, Hiramori K: Deletion polymorphism of the angiotensin I-converting enzyme gene associates with increased risk for ischemic heart diseases in the Japanese. Rinsho Byori 1995;43:347-352.
41. Mattu RK, Needham EW, Galton DJ, Frangos E, Clark AJ, Caulfield M: A DNA variant at the angiotensin converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995;91:270-274.
42. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K: Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994;90:2199-2202.
43. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F: A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis 1995;112:137-143.
44. Miettinen HE, Korpela K, Hamalainen L, Kontula K: Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet 1994;94:189-192.
45. Zingone A, Dominijanni A, Mele E, Marasco O, Melina F, Minchella P, Quaresima B, Tiano MT, Gnasso A, Pujia A, Perrotti N: Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood glucose levels. Hum Genet 1994;94:207-209.
46. Panahloo A, Andres C, Mohamed Ali V, Gould M, Panahloo A, Haines AP, Humphries S, Talmud P: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Circulation 1995;92:3390-3393.
47. Doria A, Warram JH, Krolewski AS: Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 1994;43:690-695.
48. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving HH: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995;44:489-494.
49. Ohno T, Kawazu S, Tomono S: Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 1996;45:218-222.
50. Dudley CR, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ: U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995;48:1907-1911.
51. Strojek K, Grzeszczak W, Rudzki H, Pokrzywnicki W, Lacka B, Schmidt S, Ritz E: Does an association between angiotensin I converting enzyme gene polymorphism and the prevalence of diabetic nephropathy in patients with diabetes type II exist? Pol Arch Lmed Wewn 1995;94:214-218.
52. Panagiotopoulos S, Smith TJ, Aldred GP, Baker EJ, Jacklin CJ, Jerums G: Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate. J Diabetes Complications 1995;9:272-276.
53. Fujisawa T, Ikegami H, Shen GQ, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Rakugi H, Higaki J: Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995;18:983-985.
54. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, Cambien F, Passa P, Alhenc-Gelas F: Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994;43:384-388.
55. Nagi DK, Mansfield MW, Stickland MH, Grant PJ: Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM. Diabet Med 1995;12:997-1001.
56. Pujia A, Gnasso A, Irace C, Dominijanni A, Zingone A, Perrotti N, Colonna A, Mattioli PL: Association between ACE-D/D polymorphism and hypertension in type II diabetic subjects. J Hum Hypertens 1994;8:687-691.
57. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Boelskifte S, Borch-Johnsen K: Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 1995;38:798-803.
58. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froguel P: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994;91,:3662-3665.
59. van Essen GG, Rensma PL, de Zeeuw D, Sluiter WJ, Scheffer H, Apperloo AJ, de Jong PE: Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996;347:94-95.
60. Yorioka T, Suehiro T, Yasuoka N, Hashimoto K, Kawada M: Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy. Clin Nephrol 1995;44:80-85.
61. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I, Sakai O: Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995;96:2162-2169.
62. Arbustini E, Grasso M, Leo G, Tinelli C, Fasani R, Diegoli M, Banchieri N, Cipriani A, Gorrini M, Semenzato G, Luisetti M: Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. Am J Respir Crit Care Med 1996;153:851-854.
63. Bonithon Kopp C, Ducimetiere P, Touboul PJ, Feve JM, Billaud E, Courbon D, Heraud V: Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation 1994;89:952-954.
64. Sharma P, Carter ND, Barley J, Lunt R, Seymour CA, Brown MM: Polymorphisms in the gene encoding angiotensin 1-converting enzyme and relationship to its post-translational product in cerebral infarction. J Hum Hypertens 1994;8:633-634.
65. Schachter F, Faure Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D: Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994;6:29-32.
66. Ioannidis JP, Ntzani EE, Trikalinos TA, ContopoulosIoannidis DG: Replication validity of genetic association studies. Nat Genet 2001;29:306-309.
67. Moskowitz DW: The human gene pool: Limits to human health. In: von Pfusterschmid-Hardenstein H, ed. Das Normale und das Pathologische - Was ist Gesund? Europaisches Forum Alpbach 1996. Vienna: Ibera Verlag, 1997:50-70, 680-681.
68. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1, dipeptidyl carboxypeptidase I). Nucleic Acids Res 1992;20:1433.
69. Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevin NC: ACE gene typing. Lancet 1994;343:851.
70. Rutledge DR, Browe CS, Ross EA: Frequencies of the angiotensinogen gene and angiotensin I converting enzyme (ACE) gene polymorphisms in African Americans. Biochem Mol Biol Int 1994;34:1271-1275.
71. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, Ogunlesi AO, Sagnella GA: Angiotensin converting enzyme insertion/deletion polymorphism: Association with ethnic origin. J Hypertens 1994;12:955-957.
72. Reed TE: Caucasian genes in American Negroes. Science 1969;165:762-768.
73. Adams J, Ward RH: Admixture studies and the detection of selection. Science 1973;180:1137-1143.
74. Chakraborty R, Kamboh MI, Nwankwo M, Ferrell RE: Caucasian genes in American blacks: New data. Am J Hum Genet 1992;50:145-155.
75. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, Schunkert H: Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995;92:1387-1388.
76. Kojima S, Inenaga T, Matsuoka H, Kuramochi M, Omae T, Nara Y, Yamori Y: The association between salt sensitivity of blood pressure and some polymorphic factors. J Hypertens 1994;12:797-801.
77. Dzau VJ, Gibbons GH, Morishita R, Pratt RE: New perspectives in hypertension research: Potentials of vascular biology. Hypertension 1994;23:1132-1140.
78. Greenberg DA, Doneshka P: Partitioned association-linkage test: Distinguishing 'necessary' from 'susceptibility' loci. Genet Epidemiol 1996;13:243-252.
79. White MF, Stegmann EW, Dull TJ, Ullrich A, Kahn CR: Characterization of an endogenous substrate of the insulin receptor in cultured cells. J Biol Chem 1987;262:9769-9777.
80. Moskowitz DW: From pharmacogenomics to improved patient outcomes: Angiotensin I-converting enzyme as an example. Diabetes Technol Ther 2002;4:519-531.
81. Rieder MJ, Taylor SL, Clark AG, Nickerson DA: Sequence variation in the human angiotensin converting enzyme. Nat Genet 1999;22:59-62.
82. Gallinat S, Busche S, Raizada MK, Sumners C: The angiotensin II type 2 receptor: An enigma with multiple variations. Am J Physiol Endocrinol Metab 2000;278:E357-E374.